Literature DB >> 22902264

EBV-associated plasmablastic lymphoma in a patient with Crohn's disease after adalimumab treatment.

Li Liu, Aline Charabaty, Metin Ozdemirli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22902264     DOI： 10.1016/j.crohns.2012.07.025

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  4 in total

1.  Hodgkin's lymphoma in a patient on adalimumab treatment for psoriasis.

Authors:  Nouf Alballa; Alanoud Alyousef; Albatool Alamari; Ahmed Abdullah Alhumidi; Mohammed Ayesh Zayed; Leena Zeitouni; Fahad Mohammed Alsaif
Journal:  AME Case Rep       Date:  2018-12-24

2.  Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series.

Authors:  Alejandro Llanos-Chea; Jason M Shapiro; Rachel W Winter; Logan Jerger; Timothy Menz; Meghan Gibson; Alison M Friedmann; Diana Treaba; Konstantinos Papamichael; Adam S Cheifetz; Sonia Friedman; Matthew J Hamilton; Harland S Winter
Journal:  Dig Dis Sci       Date:  2021-02-17       Impact factor: 3.199

3.  Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab.

Authors:  Chad J Hruska; Robert J Bertoli; Yorke D Young; Patrick H Burkhart; Paul B Googe
Journal:  JAAD Case Rep       Date:  2015-02-05

Review 4.  Synchronous colonic adenoma and intestinal marginal zone B-cell lymphoma associated with Crohn's disease: a case report and literature review.

Authors:  Amal Bennani; Ghizlane Kharrasse; Miry Achraf; Khanoussi Wafa; Ismaili Zahi; Kamaoui Imane; Bouziane Mohamed
Journal:  BMC Cancer       Date:  2019-10-17       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.